- Home
- AVIR vs NXG Comparison
AVIR vs NXG Comparison
Compare AVIR & NXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AVIR | NXG |
|---|---|---|
| Founded | 2012 | 2012 |
| Country | US | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 318.0M | 282.2M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | AVIR | NXG |
|---|---|---|
| Price | $4.74 | $54.04 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $6.00 | N/A |
| AVG Volume (30 Days) | ★ 580.2K | 41.0K |
| Earning Date | 04-07-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 14.78% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $351,367,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.46 | $35.22 |
| 52 Week High | $4.70 | $54.88 |
Technical Indicators
Market Signals| Indicator | AVIR | NXG |
|---|---|---|
| Relative Strength Index (RSI) | 71.86 | 74.36 |
| Support Level | $4.04 | $53.52 |
| Resistance Level | $4.50 | $54.88 |
| Average True Range (ATR) | 0.24 | 0.76 |
| MACD | 0.04 | 0.27 |
| Stochastic Oscillator | 93.23 | 82.32 |
Price Performance
Historical ComparisonAbout AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).
About NXG NXG NextGen Infrastructure Income Fund of Beneficial Interest
Cushing NextGen Infrastructure Income Fund is a closed-end investment management company. Its investment objective is to seek a high total return with a focus on current income. The Fund invests at least 80% of its net assets in a portfolio of equity and debt securities of infrastructure companies, including energy infrastructure companies, industrial infrastructure companies, sustainable infrastructure companies, and technology & communication infrastructure companies.